Organization WH. Obesity: situation and trends. Global Health Observatory (GHO) data: Risk factors; 2017.
Gortmaker SL, et al. Changing the future of obesity: science, policy, and action. The Lancet. 2011;378(9793):838–47.
Google Scholar
Poirier P, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation. 2006;113:898–918.
Google Scholar
Thompson NL, et al. Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol. 1989;108:661–9.
Google Scholar
Heine U, et al. Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol. 1987;105:2861–76.
Google Scholar
Kane CJ, et al. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol. 1991;148:157–73.
Google Scholar
Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta. Mol Genet Metab. 2000;71:418–35.
Google Scholar
Okada H, et al. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation. 2005;111:2430–7.
Google Scholar
Ikeuchi M, et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res. 2004;64:526–35.
Google Scholar
Meredith A, et al. 1,25 Dihydroxyvitamin D3 inhibits TGFβ1- mediated primary human cardiac myofibroblast activation. PLoS ONE. 2015;10(6):e0128655.
Google Scholar
Dobaczewski M, Frangogiannis N. Chemokines and cardiac fibrosis. Front Biosci (Schol Ed). 2010;1:391–405.
Google Scholar
Aukrust P, et al. Elevated circulating levels of C–C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136–43.
Google Scholar
Goser S, et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation. 2005;112:3400–7.
Google Scholar
Zhuo JL. Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease? J Hypertens. 2004;22(3):451–4.
Google Scholar
Norman DAM, Yacoub MH, Barton PJR. Nuclear factor NF-kB in myocardium: developmental expression of subunits and activation by interleukin-1b in cardiac myocytes in vitro. Cardiovasc Res. 1998;39:434–41.
Google Scholar
Zelarayan L, et al. NF-kB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res. 2009;84:416–24.
Google Scholar
Bond M, et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and – 9 production by vascular smooth muscle cells. Cardiovasc Res. 2001;50(3):556–65.
Google Scholar
Janda M, et al. Knowledge about health benefits of vitamin D in Queensland Australia. Prev Med. 2010;50(4):215–6.
Google Scholar
Hewison M. An update on vitamin D and human immunity. Clin Endocrinol. 2012;76(3):315–25.
Google Scholar
el Maaty MAA, Gad MZ. Vitamin D deficiency and cardiovascular disease: potential mechanisms and novel perspectives. J Nutri Sci Vitaminol. 2013;59(6):479–88.
Google Scholar
Jorge AJL, et al. Vitamin D deficiency and cardiovascular diseases. Int J Cardiovasc Sci. 2018;31:422–32.
Kestenbaum B, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58(14):1433–41.
Google Scholar
Jassal SK, et al. Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med. 2010;123(12):1114–20.
Google Scholar
Valcour A, et al. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metabolism. 2012;97(11):3989–95.
Google Scholar
Murr C, et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med. 2012;50(12):2205–12.
Google Scholar
Chen S, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008;52:1106–12.
Google Scholar
Rahman A, et al. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103:416–9.
Google Scholar
Argacha JF, et al. Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J Cardiovasc Pharmacol. 2011;58(1):65–71.
Google Scholar
Gode S, et al. Effect of vitamin D deficiency on the development of postoperative atrial fibrillation in coronary artery bypass patients. J Cardiovasc Thorac Res. 2016;8(4):140–6.
Google Scholar
Ramirez AM, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118(3):142–50.
Google Scholar
Zeng X, et al. Effects of 1, 25-dihydroxyvitamin D3 on expression of TGF-β1, CD68 and MCP-1 in type 2 diabetic nephropathy rat. Biomed Res. 2017;28(11):4797–802.
Zhao J-D, et al. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials. BMJ open. 2018;8(8):e020545.
Google Scholar
D’Amore C, et al. Vitamin D deficiency and clinical outcome in patients with chronic heart failure: a review. Nutr Metabolism Cardiovasc Dis. 2017;27(10):837–49.
Google Scholar
Gotsman I, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012;14(4):357–66.
Google Scholar
Farhangi MA, et al. Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat-diet induced obese rats. BMC Cardiovasc Disord. 2017;17(1):161–7.
Google Scholar
Sobesky JL, et al. High-fat diet consumption disrupts memory and primes elevations in hippocampal IL-1β, an effect that can be prevented with dietary reversal or IL-1 receptor antagonism. Brain Behav Immun. 2014;42:22–32.
Google Scholar
Sousa-Pinto B, et al. Characterization of TGF-β expression and signaling profile in the adipose tissue of rats fed with high-fat and energy-restricted diets. J Nutr Biochem. 2016;38:107–15.
Google Scholar
Farhangi MA, Mesgari-Abbasi M, Shahabi P. Cardio-renal metabolic syndrome and pro-inflammatory factors: the differential effects of dietary carbohydrate and fat. Acta Endocrinol. 2019;15(4):436–41.
Karimi E, et al. High carbohydrate intakes may predict more inflammatory status than high fat intake in pre-menopause women with overweight or obesity: a cross-sectional study. BMC Res Note. 2021;14:279–85.
Sirjani M, et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. Iran J Allergy Asthma Immunol. 2014;13(4):247–55.
Mousavi SN, et al. Comparison of maternal isocaloric high carbohydrate and high fat diets on osteogenic and adipogenic genes expression in adolescent mice offspring. Nutr Metab. 2016;13(1):69–72.
Google Scholar
Irani M, et al. Vitamin D supplementation decreases TGF-β1 bioavailability in PCOS: a randomized placebo-controlled trial. J Clin End Met. 2015;100(11):4307–14.
Google Scholar
Aschenbrenner JK, et al. 1, 25-(OH2) D3 alters the transforming growth factor β signaling pathway in renal tissue. J Surg Res. 2001;100(2):171–5.
Google Scholar
Calton EK, et al. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS ONE. 2015;10(11):e0141770.
Google Scholar
Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annual Rev Pharm Toxicol. 2011;51:311–36.
Google Scholar
Wang YC, et al. Effect of vitamin D3 on monocyte chemoattractant protein 1 production in monocytes and macrophages. Acta Cardiol Sinica. 2014;30(2):144.
Matoba T, Egashira K. Anti-inflammatory gene therapy for cardiovascular disease. Curr Gene Ther. 2011;11:442–6.
Google Scholar
Mousa A, et al. Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Sci Rep. 2017;7:15154.
Google Scholar
Chen Y, et al. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J Biol Chem. 2013;288(27):19450–8.
Google Scholar
Agrawal DK. Vitamin D and immunomodulation in coronary artery disease. In: Department of Clinical and Translational Science. United States of America: Creighton University; 2017.
